HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Aikata Selected Research

Non-alcoholic Fatty Liver Disease

4/2023Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report.
1/2022Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.
1/2022Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
8/2020Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
1/2019HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
7/2018A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.
2/2018Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
2/2017The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
3/2016Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus.
1/2016Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Aikata Research Topics

Disease

143Hepatocellular Carcinoma (Hepatoma)
04/2024 - 09/2002
60Neoplasms (Cancer)
02/2024 - 01/2007
46Infections
01/2023 - 04/2009
29Chronic Hepatitis C
01/2021 - 01/2007
26Neoplasm Metastasis (Metastasis)
10/2021 - 01/2007
24Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 10/2007
22Fibrosis (Cirrhosis)
02/2024 - 10/2007
20Thrombosis (Thrombus)
06/2023 - 10/2007
13Non-alcoholic Fatty Liver Disease
04/2023 - 03/2014
12Chronic Hepatitis B
01/2021 - 08/2010
12Hepatitis C
09/2020 - 06/2007
10Liver Diseases (Liver Disease)
03/2022 - 11/2011
9Esophageal and Gastric Varices (Esophageal Varices)
01/2021 - 01/2008
8Liver Neoplasms (Liver Cancer)
12/2023 - 05/2009
8Portal Hypertension
04/2023 - 01/2008
8Hepatitis B
01/2023 - 03/2015
8Hepatic Encephalopathy
11/2020 - 03/2011
7Hepatitis
01/2021 - 08/2008
6Disease Progression
04/2020 - 12/2010
5Chronic Hepatitis (Chronic Active Hepatitis)
01/2023 - 03/2017
4Cholangiocarcinoma
01/2022 - 05/2009
4Hemorrhage
01/2021 - 01/2008
4Edema (Dropsy)
02/2020 - 08/2016
4Type 2 Diabetes Mellitus (MODY)
01/2018 - 03/2014
4Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
05/2017 - 08/2012
3Carcinogenesis
04/2023 - 01/2016
3Pancreatitis
08/2022 - 10/2014
3Sarcopenia
07/2022 - 03/2019
3Insulin Resistance
03/2022 - 12/2014
3Lymphatic Metastasis
01/2022 - 08/2012
3Liver Failure
02/2021 - 01/2008
3Varicose Veins (Varicose Vein)
11/2020 - 05/2002
3Brain Diseases (Brain Disorder)
08/2019 - 03/2013
3Acute Liver Failure (Fulminant Hepatic Failure)
12/2017 - 08/2014
3Anemia
06/2017 - 05/2013
3Carcinoma (Carcinomatosis)
06/2015 - 07/2011

Drug/Important Bio-Agent (IBA)

41InterferonsIBA
01/2021 - 10/2007
34Sorafenib (BAY 43-9006)FDA Link
09/2023 - 01/2012
27lenvatinibIBA
04/2024 - 01/2019
23Antiviral Agents (Antivirals)IBA
01/2023 - 05/2012
21Ribavirin (Virazole)FDA LinkGeneric
12/2020 - 01/2007
14daclatasvirIBA
01/2020 - 01/2014
13asunaprevirIBA
01/2020 - 01/2015
11Cisplatin (Platino)FDA LinkGeneric
04/2024 - 09/2002
10Bevacizumab (Avastin)FDA Link
03/2024 - 08/2021
10atezolizumabIBA
03/2024 - 08/2021
10Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2016
10RNA (Ribonucleic Acid)IBA
01/2023 - 06/2008
10Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 10/2007
8Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2023 - 01/2017
8AntigensIBA
01/2021 - 10/2015
7Proteins (Proteins, Gene)FDA Link
08/2023 - 07/2016
7Capsules (Microcapsules)IBA
07/2022 - 05/2013
7Glucose (Dextrose)FDA LinkGeneric
03/2022 - 03/2014
7DNA (Deoxyribonucleic Acid)IBA
11/2021 - 09/2015
6Alanine Transaminase (SGPT)IBA
04/2024 - 03/2014
6NucleotidesIBA
01/2023 - 01/2017
6SofosbuvirIBA
12/2020 - 04/2017
6Interferon-alpha (Interferon Alfa)IBA
04/2009 - 01/2007
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2024 - 12/2014
5Hemoglobins (Hemoglobin)IBA
04/2023 - 05/2015
5telaprevirIBA
06/2016 - 10/2014
5Ethiodized Oil (Ethiodol)FDA Link
07/2013 - 09/2002
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2023 - 05/2016
4BilirubinIBA
08/2023 - 12/2017
4AlbuminsIBA
08/2023 - 07/2016
4Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 04/2015
4EnzymesIBA
02/2021 - 06/2008
4Immunoglobulins (Immunoglobulin)IBA
01/2021 - 10/2015
4regorafenibIBA
01/2021 - 09/2018
4Fetal Proteins (Fetoprotein)IBA
11/2020 - 01/2012
4ChemokinesIBA
03/2020 - 01/2016
4CytokinesIBA
01/2020 - 01/2016
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2017 - 08/2012
4SimeprevirIBA
03/2017 - 06/2016
3Serum AlbuminIBA
08/2023 - 11/2011
3Complementary DNA (cDNA)IBA
01/2023 - 05/2017
3Immune Checkpoint InhibitorsIBA
11/2022 - 10/2020
3pembrolizumabIBA
08/2022 - 07/2020
3Circulating Tumor DNAIBA
06/2021 - 09/2015
3Prothrombin (Factor II)IBA
01/2021 - 12/2014
3ChromatinIBA
01/2021 - 05/2018
3Immunoglobulin G (IgG)IBA
01/2021 - 06/2008
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2020
3Protease Inhibitors (Protease Inhibitor)IBA
04/2020 - 11/2014
3AmmoniaIBA
08/2019 - 12/2018
3NucleosidesIBA
01/2019 - 01/2018
3ledipasvirIBA
12/2018 - 04/2017
3Zoledronic Acid (Zometa)FDA Link
09/2017 - 12/2010
3Hyaluronic Acid (Hyaluronan)IBA
07/2016 - 01/2016

Therapy/Procedure

100Therapeutics
03/2024 - 01/2007
33Drug Therapy (Chemotherapy)
04/2024 - 04/2008
18Radiotherapy
06/2023 - 12/2010
18Liver Transplantation
01/2023 - 06/2007
15Hepatectomy
12/2023 - 08/2012
6Surgical Portasystemic Shunt (Portosystemic Shunt)
08/2019 - 03/2011
5Radiofrequency Ablation
01/2020 - 03/2010
4Splenectomy
04/2023 - 06/2007
4Sclerotherapy
01/2021 - 01/2009
3Conformal Radiotherapy
06/2015 - 01/2009